177 related articles for article (PubMed ID: 27895888)
41. Design of hydrogels to stabilize and enhance bone morphogenetic protein activity by heparin mimetics.
Kim S; Cui ZK; Kim PJ; Jung LY; Lee M
Acta Biomater; 2018 May; 72():45-54. PubMed ID: 29597024
[TBL] [Abstract][Full Text] [Related]
42. Controlled and Extended In Vitro Release of Bioactive Anti-Vascular Endothelial Growth Factors from a Microsphere-Hydrogel Drug Delivery System.
Osswald CR; Kang-Mieler JJ
Curr Eye Res; 2016 Sep; 41(9):1216-22. PubMed ID: 26764892
[TBL] [Abstract][Full Text] [Related]
43. Microparticulate poly(vinyl alcohol) hydrogel formulations for embedding and controlled release of polyethylenimine (PEI)-based nanoparticles.
Schulze J; Hendrikx S; Schulz-Siegmund M; Aigner A
Acta Biomater; 2016 Nov; 45():210-222. PubMed ID: 27592816
[TBL] [Abstract][Full Text] [Related]
44. Triethyl orthoformate covalently cross-linked chitosan-(poly vinyl) alcohol based biodegradable scaffolds with heparin-binding ability for promoting neovascularisation.
Shahzadi L; Yar M; Jamal A; Siddiqi SA; Chaudhry AA; Zahid S; Tariq M; Rehman IU; MacNeil S
J Biomater Appl; 2016 Oct; 31(4):582-593. PubMed ID: 27189757
[TBL] [Abstract][Full Text] [Related]
45. Improved vascularization of porous scaffolds through growth factor delivery from heparinized polyethylene glycol hydrogels.
Janse van Rensburg A; Davies NH; Oosthuysen A; Chokoza C; Zilla P; Bezuidenhout D
Acta Biomater; 2017 Feb; 49():89-100. PubMed ID: 27865963
[TBL] [Abstract][Full Text] [Related]
46. Heparin desulfation modulates VEGF release and angiogenesis in diabetic wounds.
Freudenberg U; Zieris A; Chwalek K; Tsurkan MV; Maitz MF; Atallah P; Levental KR; Eming SA; Werner C
J Control Release; 2015 Dec; 220(Pt A):79-88. PubMed ID: 26478015
[TBL] [Abstract][Full Text] [Related]
47. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin.
Jeon O; Ryu SH; Chung JH; Kim BS
J Control Release; 2005 Jul; 105(3):249-59. PubMed ID: 16088988
[TBL] [Abstract][Full Text] [Related]
48. Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis.
Kim MS; Bhang SH; Yang HS; Rim NG; Jun I; Kim SI; Kim BS; Shin H
Tissue Eng Part A; 2010 Oct; 16(10):2999-3010. PubMed ID: 20486788
[TBL] [Abstract][Full Text] [Related]
49. A photo-crosslinked poly(vinyl alcohol) hydrogel growth factor release vehicle for wound healing applications.
Bourke SL; Al-Khalili M; Briggs T; Michniak BB; Kohn J; Poole-Warren LA
AAPS PharmSci; 2003 Dec; 5(4):E33. PubMed ID: 15198521
[TBL] [Abstract][Full Text] [Related]
50. Poly(vinyl alcohol)-heparin biosynthetic microspheres produced by microfluidics and ultraviolet photopolymerisation.
Young C; Rozario K; Serra C; Poole-Warren L; Martens P
Biomicrofluidics; 2013; 7(4):44109. PubMed ID: 24404042
[TBL] [Abstract][Full Text] [Related]
51. Synergistic interplay between human MSCs and HUVECs in 3D spheroids laden in collagen/fibrin hydrogels for bone tissue engineering.
Heo DN; Hospodiuk M; Ozbolat IT
Acta Biomater; 2019 Sep; 95():348-356. PubMed ID: 30831326
[TBL] [Abstract][Full Text] [Related]
52. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release.
Chinen N; Tanihara M; Nakagawa M; Shinozaki K; Yamamoto E; Mizushima Y; Suzuki Y
J Biomed Mater Res A; 2003 Oct; 67(1):61-8. PubMed ID: 14517862
[TBL] [Abstract][Full Text] [Related]
53. Effect of gelatin on heparin regulation of cytokine release from hyaluronan-based hydrogels.
Peattie RA; Pike DB; Yu B; Cai S; Shu XZ; Prestwich GD; Firpo MA; Fisher RJ
Drug Deliv; 2008 Aug; 15(6):389-97. PubMed ID: 18686083
[TBL] [Abstract][Full Text] [Related]
54. Dual Aptamer-Functionalized in Situ Injectable Fibrin Hydrogel for Promotion of Angiogenesis via Codelivery of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor-BB.
Zhao N; Suzuki A; Zhang X; Shi P; Abune L; Coyne J; Jia H; Xiong N; Zhang G; Wang Y
ACS Appl Mater Interfaces; 2019 May; 11(20):18123-18132. PubMed ID: 31026135
[TBL] [Abstract][Full Text] [Related]
55. Controlled Release of Vascular Endothelial Growth Factor from Heparin-Functionalized Gelatin Type A and Albumin Hydrogels.
Claaßen C; Sewald L; Tovar GEM; Borchers K
Gels; 2017 Oct; 3(4):. PubMed ID: 30920532
[TBL] [Abstract][Full Text] [Related]
56. Angiogenesis Promotion by Combined Administration of DFO and Vein Endothelial Cells Using Injectable, Biodegradable, Nanocomposite Hydrogel Scaffolds.
Ono K; Sumiya M; Yoshinobu N; Dode T; Katayama T; Ueda N; Nagahama K
ACS Appl Bio Mater; 2022 Feb; 5(2):471-482. PubMed ID: 35045699
[TBL] [Abstract][Full Text] [Related]
57. Fibroblast-derived matrix (FDM) as a novel vascular endothelial growth factor delivery platform.
Du P; Hwang MP; Noh YK; Subbiah R; Kim IG; Bae SE; Park K
J Control Release; 2014 Nov; 194():122-9. PubMed ID: 25194780
[TBL] [Abstract][Full Text] [Related]
58. Influence of citric acid on the physical and biomineralization ability of freeze/thaw poly(vinyl alcohol) hydrogel.
Wahid MNA; Abd Razak SI; Abdul Kadir MR; Hassan R; Nayan NHM; Mat Amin KA
J Biomater Appl; 2018 Jul; 33(1):94-102. PubMed ID: 29716417
[TBL] [Abstract][Full Text] [Related]
59. Comparative Study of Heparin-Poloxamer Hydrogel Modified bFGF and aFGF for in Vivo Wound Healing Efficiency.
Wu J; Zhu J; He C; Xiao Z; Ye J; Li Y; Chen A; Zhang H; Li X; Lin L; Zhao Y; Zheng J; Xiao J
ACS Appl Mater Interfaces; 2016 Jul; 8(29):18710-21. PubMed ID: 27384134
[TBL] [Abstract][Full Text] [Related]
60. Dual delivery of stem cells and insulin-like growth factor-1 in coacervate-embedded composite hydrogels for enhanced cartilage regeneration in osteochondral defects.
Cho H; Kim J; Kim S; Jung YC; Wang Y; Kang BJ; Kim K
J Control Release; 2020 Nov; 327():284-295. PubMed ID: 32763434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
